Cell Cycle Analysis Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2025
Cell proliferation regulation is a central part of the tissue morphogenesis process during the development of multicellular organisms. Moreover, the loss of control of cell proliferations is one of the underlying factors to consider in case of diseases such as cancer. As the patient base of a number of cancers continue to expand at an enormous pace across the globe, a great need is being felt for the investigation of cell proliferation and measure the proportion of sells in every phase of the cell cycle of the cell under observation.
It is also highly essential to imprecisely identify cells that are replicating their DNAs within a large population of cells. As a cell’s decision regarding proliferation is made in the G1 phase of development, immediately before the initiation of the process of DNA synthesis and before the rest of the cell cycle progresses, researchers state that the detection of DNA synthesis of a cell at this stage helps in the unambiguous determination of the status of growth regulation in experiments related to cell culture. The increasing number of research fields making use of data generated from such analysis, the market for cell cycle analysis is witnessing significant traction globally.
The market is expected to expand at a healthy pace in the next few years owing to the rising set of applications across a number of fields. The market is expected to benefit significantly from the vast technological advancements witnessed in the field of cell cycle analysis consumables.
Cell Cycle analysis is a highly demanded method for the evaluation of cells in the diverse phases of cell cycle. The determination of cellular response to a variety of drugs and biological stimulations is one of the trending elements prevailing in the global cell cycle analysis market. Most of the methods used during the analysis of cell cycle are based on florescence assays. Dominating sectors such as clinical diagnosis and biomedical research are observed to extensively employ cell cycle analysis.
For a better understanding of the global cell cycle analysis market, the segmentation pattern could follow as based on parameters such as method, application, product, and end user. The geographical segmentation of the global market helps to find the most lucrative regions and the rising demand of different segments in different geographies.
The report presented here can be tailor-made by our adept analysts as per the requirements of the buyers. All research publications compiled by TMR Research provide a comprehensive examination of the market in discussion based on volume and value. Additionally, the market share of each leading player is carefully analyzed to chart the competitive landscape, also considering other decisive aspects.
With a secure growth rate, the international cell cycle analysis market is foretold to rise with the help of the support from government and corporate sectors for cell-based researches. The prevalence of menacing diseases has augmented the demand for cell cycle analysis in the global market. Increasing incidence of cancer and greater pervasiveness of chronic genetic disorders are good examples of the aforementioned growth driver. Likewise, the existence of the healthcare industry since several years, supported by tangible growth, has made its contribution for the sustenance of the market.
Howbeit, the expensive prices of automated instruments could apply brakes to the progress of the global cell cycle analysis market. Besides this, it is infeasible for small research groups to bear the maintenance cost of advanced cell cycle analysis instruments. Nonetheless, the perpetual technological developments in this sector have pushed the market growth to a significant high. The rising awareness and adoption of cell cycle analysis instruments on a global platform are also expected to make up for the cutbacks in the market.
One of the most important types of segmentation of the world cell cycle analysis market is based on application. Amongst the primary application segments of the global market, research is anticipated to register a higher CAGR and emerge as a prominent segment. Much of the demand for this segment is expected to rise from the growing corporate and government support aimed toward the betterment of cell-based assays. Other markets that fall under the application segmentation could be therapeutics and diagnosis.
The markets under the consumable segmentation by product are analyzed to ride on the unabating increase in the cases of genetic diseases globally. Some of the key consumable segments could be reagents and kits and assays.
The global cell cycle analysis market is also segmented as per type of method, out of which cytometry is predicted to register a commanding growth. Other salient segments of this classification could be microscopy, cell counting, and cell imaging.
The end-user market for world cell cycle analysis market is foretold to count its growth on the elevating occurrences of genetic and cancer related diseases. Pharmaceutical contract research organizations (CROs) and biotechnology companies, hospitals and diagnostic laboratories, and academics and research institutions could be the vital segments listed under the end-user category.
Owing to the surging focus on Asia Pacific coupled with the increasing awareness about self-monitoring, the region is prophesied to grow at a faster pace. Another chief factor that is adding to the advancement of the Asia Pacific market includes the heavy investments made by major international companies. India, Japan, and China could be the most demanding countries of the Asia Pacific region.
Amongst the other regions, North America has always secured its leading position in the global cell cycle analysis market by accounting for a larger share. In terms of market share, Europe could be following North America on the back of its major driving factors.
With the help of a strong sales network, avant-garde manufacturing facilities, and robust distribution system, the prominent players in the world cell cycle analysis market are anticipated to take charge. Some of these players are Agilent Technologies, Inc., GE Healthcare, Merck KGAA, Miltenyi Biotech, Affymetrix, Inc., PerkinElmer, Inc., Danaher Corporation, Nexcelom Bioscience LLC, Olympus Corporation, and Dickinson and Company.
The study presents a granular assessment and quantitative evaluation of:
The region-wise assessment includes market dynamics in:
The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.
The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:
Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.
Flat 10% discount on Single User License if you prebook this report
Flat 10% discount on Multiple User License if you prebook this report
Flat 10% discount on Corporate License if you prebook this report